DK0471660T3 - Protein C til behandling af smerte - Google Patents

Protein C til behandling af smerte

Info

Publication number
DK0471660T3
DK0471660T3 DK91890012.7T DK91890012T DK0471660T3 DK 0471660 T3 DK0471660 T3 DK 0471660T3 DK 91890012 T DK91890012 T DK 91890012T DK 0471660 T3 DK0471660 T3 DK 0471660T3
Authority
DK
Denmark
Prior art keywords
protein
pain
treatment
compsn
prepare
Prior art date
Application number
DK91890012.7T
Other languages
Danish (da)
English (en)
Inventor
Johann Dr Eibl
Ludwig Prof Dr Pichler
Hans-Peter Doz Dr Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of DK0471660T3 publication Critical patent/DK0471660T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91890012.7T 1990-08-16 1991-01-28 Protein C til behandling af smerte DK0471660T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0169790A AT402260B (de) 1990-08-16 1990-08-16 Protein c-hältige pharmazeutische präparation

Publications (1)

Publication Number Publication Date
DK0471660T3 true DK0471660T3 (da) 1995-12-18

Family

ID=3519039

Family Applications (3)

Application Number Title Priority Date Filing Date
DK91890012.7T DK0471660T3 (da) 1990-08-16 1991-01-28 Protein C til behandling af smerte
DK92117249.0T DK0533210T3 (da) 1990-08-16 1991-01-28 Protein C-holdige farmaceutiske præparater som midler mod inflammation.
DK92117248.2T DK0533209T3 (da) 1990-08-16 1991-01-28 Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK92117249.0T DK0533210T3 (da) 1990-08-16 1991-01-28 Protein C-holdige farmaceutiske præparater som midler mod inflammation.
DK92117248.2T DK0533209T3 (da) 1990-08-16 1991-01-28 Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum.

Country Status (12)

Country Link
EP (3) EP0471660B1 (cs)
JP (1) JP2530770B2 (cs)
AT (6) AT402260B (cs)
CA (1) CA2041380C (cs)
CZ (1) CZ280004B6 (cs)
DE (3) DE59108697D1 (cs)
DK (3) DK0471660T3 (cs)
ES (3) ES2103861T3 (cs)
HR (1) HRP921237A2 (cs)
HU (1) HUT60147A (cs)
RU (1) RU2066550C1 (cs)
YU (1) YU77591A (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
AT397615B (de) * 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
ES2179129T3 (es) * 1995-03-21 2003-01-16 Baxter Ag Agente para la aplicacion subcutanea de la proteina c.
DE19608218A1 (de) * 1995-03-21 1996-09-26 Immuno Ag Mittel zur subkutanen Verabreichung von Protein C
EP1841442A4 (en) * 2005-01-07 2009-12-09 Northern Sydney And Central Co TREATMENT OF AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES
ES2676422T3 (es) * 2012-07-04 2018-07-19 Zz Biotech Llc Proteína C activada para su uso en el tratamiento de trastornos inflamatorios de la piel
PT3131572T (pt) 2014-04-16 2021-09-24 Zz Biotech Llc Análogo de apc para utilização em cicatrização de feridas
ES2890675T3 (es) 2014-04-16 2022-01-21 Zz Biotech Llc APC para uso en el tratamiento de cicatrices cutáneas anormales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock

Also Published As

Publication number Publication date
CA2041380A1 (en) 1992-02-17
HUT60147A (en) 1992-08-28
CS121391A3 (en) 1992-02-19
ATE126699T1 (de) 1995-09-15
EP0471660A2 (de) 1992-02-19
ATA20392A (de) 1997-07-15
DK0533210T3 (da) 1997-11-03
HRP921237A2 (en) 1995-10-31
JPH04230633A (ja) 1992-08-19
ATE152354T1 (de) 1997-05-15
ES2080289T3 (es) 1996-02-01
RU2066550C1 (ru) 1996-09-20
ES2103861T3 (es) 1997-10-01
ATA20492A (de) 1997-10-15
AT403763B (de) 1998-05-25
CZ280004B6 (cs) 1995-09-13
AT403439B (de) 1998-02-25
ATE150649T1 (de) 1997-04-15
EP0533210B1 (de) 1997-05-02
ATA169790A (de) 1996-08-15
EP0471660A3 (en) 1992-04-15
DE59108697D1 (de) 1997-06-05
AT402260B (de) 1997-03-25
DE59108638D1 (de) 1997-04-30
DK0533209T3 (da) 1997-09-22
HU911348D0 (en) 1991-10-28
EP0533210A1 (de) 1993-03-24
JP2530770B2 (ja) 1996-09-04
CA2041380C (en) 1997-10-07
EP0533209B1 (de) 1997-03-26
ES2102435T3 (es) 1997-08-01
EP0533209A1 (de) 1993-03-24
DE59106292D1 (de) 1995-09-28
EP0471660B1 (de) 1995-08-23
YU77591A (sh) 1995-10-24

Similar Documents

Publication Publication Date Title
DE68920775D1 (de) Behandlung von faserigen Materialien.
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
DE69325772D1 (de) Implantierbarer Herzschrittmacher mit anpassbarem AV-Intervall zur Behandlung von Kardiomyopathie
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
LV5824A4 (lv) Cilveku psihozes arstesanas panemiens
DE59106292D1 (de) Protein C zur Schmerzbekämpfung.
FI841161A7 (fi) Yhdiste ja koostumus terapeuttista tai diagnostista käyttöä varten sekä terapeuttinen hoitomenetelmä.
DE58902451D1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
DE69132782D1 (de) Verwendung von angiotensin-ii-antagonisten in der behandlung der linken ventrikulären hypertrophie
AT386021B (de) Verfahren zur alkalischen behandlung von natuerlichen cellulosefasern und deren mischungen mit synthesefasern
DE69120021D1 (de) Anwendung von Makrophagen Kolonie-stumulierendem Faktor in der Behandlung von Cachexia
ATE91889T1 (de) Verfahren zur behandlung von brandwunden.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE33936T1 (de) Apparat zur aeusseren behandlung von koerperteilen mit akustischen wellen.
DE69133542D1 (de) Katheter zur Behandlung von Prostaterkrankungen
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DK435889D0 (da) Delimbing of blood specially for human
SE8302723D0 (sv) Behandling av brensletorv
RO87034A2 (ro) Medicament pentru tratamentul afectiunilor reumatismale
CU20924A (es) Procedimiento para la purificacion del factor v humano y el antisuero anti factor v
NO923888D0 (no) Kalsitoningen-relatert peptid for behandling av retinert testikkel
SE8300874D0 (sv) Forfarande och anordning for behandling av fororenat vatten
NO904288L (no) Paavisning av human vevsfaktoraktivator.
SE9004160D0 (sv) Method of treating pain
DE69133298D1 (de) Verwendung von acetylierten Mannanderivaten zur Behandlung von chronischen Atemwegserkrankungen

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment